VACCINEX INC (VCNX)
US9186403013 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.53M | 6.39M | 8.59M | 10.60M | 2.78M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 961.00K | 180.00K | 0.00 | 160.00K | 900.00K | |||
| Other Current Assets | 853.00K | 910.00K | 820.00K | 530.00K | 340.00K | |||
| Total Current Assets | 3.35M | 7.48M | 9.41M | 11.29M | 4.01M | |||
| Non-Current Assets | ||||||||
| PPE Net | 282.00K | 500.00K | 440.00K | 420.00K | 590.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 282.00K | 500.00K | 430.00K | 410.00K | 590.00K | |||
| TOTAL ASSETS | 3.63M | 7.98M | 9.84M | 11.70M | 4.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 8.07M | 0.00 | |||
| Current Portion Of LT Debt. | 75.00K | 70.00K | 70.00K | N/A | N/A | |||
| Accrued Expenses | 1.39M | 950.00K | 1.12M | 1.94M | 3.67M | |||
| Accounts Payable | 2.04M | 1.52M | 1.06M | 3.17M | 3.21M | |||
| Other Current Liabilities | 2.41M | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 5.92M | 2.54M | 2.26M | 13.18M | 6.88M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 26.00K | 100.00K | 180.00K | 1.13M | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 150.00K | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 26.00K | 240.00K | 170.00K | 25.10M | 23.96M | |||
| TOTAL LIABILITIES | 5.94M | 2.78M | 2.43M | 38.28M | 30.84M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -339.93M | -319.68M | -299.86M | -277.48M | -248.63M | |||
| Additional Paid In Capital | 337.63M | 324.88M | 307.28M | 250.91M | 222.40M | |||
| Minority Interest | N/A | N/A | 0.00 | 23.96M | 23.96M | |||
| Common Shares | 90.00 | 10.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -11.00K | -10.00K | -10.00K | -10.00K | -10.00K | |||
| Other Shareholders' Equity | -90.00 | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 892.62K | 3.33M | 2.05M | 1.49M | 990.00K | |||
| Tangible Book Value per Share | -2.59 | 1.56 | 3.61 | -17.84 | -26.51 | |||
| Total Shareholders' Equity | -2.31M | 5.19M | 7.41M | -26.58M | -26.24M | |||
| TOTAL LIABILITIES AND EQUITY | 3.63M | 7.98M | 9.84M | 11.70M | 4.60M | |||
| Statistics | ||||||||
| Debt/Equity | -0.01 | 0.02 | 0.02 | -0.35 | N/A | |||
| Current Ratio | 0.57 | 2.94 | 4.16 | 0.86 | 0.58 | |||
| Return On Assets (ROA) | -557.73% | -248.37% | -227.44% | -246.58% | -692.61% | |||
| Return On Equity (ROE) | N/A | -381.89% | -302.02% | N/A | N/A | |||
All data in USD